Veeva Systems Inc. is the dominant SaaS provider for life sciences, with 80% market share and a highly diversified, resilient customer base. Despite a 40% share price drawdown, VEEV maintains robust fundamentals: 16% revenue growth, >75% gross margins, and a net cash balance covering 20% of its market cap. AI disruption fears are overblown; VEEV's deep domain expertise, integrated platform, and high switching costs underpin a durable competitive moat.
VEEV's strong Q3, expanding AI strategy and major life sciences partnerships fuel growth despite rising costs.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Veeva Systems (VEEV) concluded the recent trading session at $209.98, signifying a -3.67% move from its prior day's close.
Veeva (VEEV) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Veeva Systems (VEEV) closed the most recent trading day at $222, moving 1.46% from the previous trading session.
The latest trading day saw Veeva Systems (VEEV) settling at $225.28, representing a +2.53% change from its previous close.
Veeva Systems (VEEV) concluded the recent trading session at $222.21, signifying a +1.49% move from its prior day's close.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks.com users have recently been watching Veeva (VEEV) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Veeva Systems Inc. (VEEV) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript